Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia
- 25 July 1992
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 340 (8813), 199-202
- https://doi.org/10.1016/0140-6736(92)90467-h
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The history of clozapinePsychopharmacology, 1989
- Dopamine receptors in human brain: Autoradiographic distribution of D2 sitesNeuroscience, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamideJournal of Medicinal Chemistry, 1988
- Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivoEuropean Journal of Pharmacology, 1986
- Schizophrenia with Good and Poor Outcome. I: Early Clinical Features, Response to Neuroleptics and Signs of Organic DysfunctionThe British Journal of Psychiatry, 1985
- Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potencyAmerican Journal of Psychiatry, 1980
- MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIAThe Lancet, 1978
- The Global Assessment ScaleArchives of General Psychiatry, 1976
- THE BRIEF PSYCHIATRIC RATING SCALEPsychological Reports, 1962